A suit against Novartis and Vitaris by Henrietta Lacks’ estate hinges on questions about the morality and legality of using ...

Torrent Pharmaceuticals Limited, the flagship Company of the ... The Company entered into a License Agreement with Novartis granting global rights for further development and commercialization ...

The symposium took place during the 2024 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, with the ...

Discover the benefits of international dividend plays with HDEF, with a focus on Financials and Consumer Staples, offering ...

Basel, October 18, 2024 – Novartis announced today that the Committee ... particularly for patients who currently have limited treatment options, including those with high-risk node-negative ...

SALES FORECAST: Novartis's third-quarter sales are forecast at $12.62 billion, according to a consensus of analysts' estimates compiled by Visible Alpha. This compares with $11.78 billion the year ...

Doctors & patients confirm acute shortage of the drug in hospitals, even as manufacturer Novartis maintains there is no ...

Basel: This month, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated to ...

Novartis ribociclib recognized as Category 1 preferred breast cancer adjuvant treatment by NCCN Guidelines: Basel Saturday, October 26, 2024, 14:00 Hrs [IST] This month, the NCCN ...

Novartis is one of the world's top pharmaceutical companies ... In 1970, Ciba and Geigy merged to form Ciba-Geigy Ltd. Ten years later, a biotechnology unit was established.

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.